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Abstract
Background: Determining the expression levels of microRNAs (miRNAs) is of great interest to
researchers in many areas of biology, given the significant roles these molecules play in cellular
regulation. Two common methods for measuring miRNAs in a total RNA sample are microarrays
and quantitative RT-PCR (qPCR). To understand the results of studies that use these two different
techniques to measure miRNAs, it is important to understand how well the results of these two
analysis methods correlate. Since both methods use total RNA as a starting material, it is also
critical to understand how measurement of miRNAs might be affected by the particular method of
total RNA preparation used.
Results: We measured the expression of 470 human miRNAs in nine human tissues using Agilent
microarrays, and compared these results to qPCR profiles of 61 miRNAs in the same tissues. Most
expressed miRNAs (53/60) correlated well (R > 0.9) between the two methods. Using spiked-in
synthetic miRNAs, we further examined the two miRNAs with the lowest correlations, and found
the differences cannot be attributed to differential sensitivity of the two methods. We also tested
three widely-used total RNA sample prep methods using miRNA microarrays. We found that while
almost all miRNA levels correspond between the three methods, there were a few miRNAs whose
levels consistently differed between the different prep techniques when measured by microarray
analysis. These differences were corroborated by qPCR measurements.
Conclusion: The correlations between Agilent miRNA microarray results and qPCR results are
generally excellent, as are the correlations between different total RNA prep methods. However,
there are a few miRNAs whose levels do not correlate between the microarray and qPCR
measurements, or between different sample prep methods. Researchers should therefore take
care when comparing results obtained using different analysis or sample preparation methods.
Background
MicroRNAs (miRNAs) are small (~18–24 nucleotides)
non-coding RNAs which bind to mRNAs to regulate pro-
tein expression, either by blocking translation and/or by
promoting degradation of the mRNA target (reviewed in
[1-3]), or alternatively by increasing translation [4,5].
They have been found to be involved in numerous func-
tions such as cell fate determination, cell proliferation,
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cell differentiation, and cell death (reviewed in [6,7]).
Profiles of miRNAs in various types of tumors have been
shown to contain potential diagnostic and prognostic
information (reviewed in [8,9]). The number of known
miRNAs has rapidly increased in recent years, and cur-
rently there are 722 human miRNA sequences reported in
the Sanger Institute's miRNA database release 10.0 (miR-
Base) [10-12], with potentially many more yet to be
reported [13,14].
Several methods for global miRNA profiling are currently
in common use. These include quantitative RT-PCR
(qPCR) involving stem-loop RT primers combined with
TaqMan PCR (Applied Biosystems) analysis [15,16],
qPCR with locked nucleic acid primers (Exiqon) [17],
qPCR using poly(A) tailing (QIAGEN, Stratagene)
[18,19], high-throughput sequencing of small RNA librar-
ies [20], and microarray analysis (for examples, see [21-
26]). Typical experimental workflows often involve using
different methods of measuring miRNAs at different
research stages. For this reason, it is important to know
how well the different measurements agree with each
other. Several groups have compared microarray profiling
results with those obtained by quantitative PCR for either
a small number of genes or a small set of samples
[21,22,26-30]; however there has been no systematic
comparison of larger numbers of miRNAs across a widely
diverse range of human tissues using the two methods.
In this study, we compared the relative expression of 61
different miRNAs across nine different human tissues,
measured using both Agilent miRNA microarrays and
TaqMan qPCR. The Agilent microarray platform features
the direct end-labeling and profiling of mature miRNAs
from total RNA without any size fractionation or amplifi-
cation to minimize experimental loss, bias, or variations
[31,32]. The labeling reaction is performed under dena-
turing conditions to provide high labeling yield, minimal
sequence bias [26], and consistently reproducible effi-
ciency for every miRNA sequence [31,32]. By incorporat-
ing hairpin structures in the microarray probe, base-
pairing with the additional nucleotide incorporated dur-
ing labeling, and empirical melting point-determination,
the platform is capable of single-nucleotide discrimina-
tion in the miRNA sequences while specifically distin-
guishing the mature miRNAs from longer RNAs in the
total RNA sample [26,31,32]. We chose to compare this
microarray system against the Taqman qPCR system in
particular, since at the time this work was performed this
was the most commonly utilized miRNA qPCR system.
We found excellent correlation between the microarray
and PCR results for most of the miRNAs. We further exam-
ined two of the miRNAs showing low correlations by
using spiked-in synthetic RNAs, and found that differen-
tial sensitivity between the two techniques is not the cause
of the discrepancy.
Another factor which could potentially affect the results of
an miRNA profiling study is the method used to isolate
RNA from the biological sample. Both the Agilent micro-
array system and the TaqMan qPCR systems use total RNA
as the starting material; however, it is unclear whether dif-
ferent total RNA preparation methods will yield systemat-
ically different miRNA profiling results. In this report, we
compared the results of miRNA microarray profiling
obtained with three different commonly used total RNA
prep methods. We found that the results for most miRNAs
were equivalent among the different sample preparation
methods, but that measured levels of a small number of
miRNAs differed systematically.
Results and discussion
Quantitative RT-PCR and Agilent microarray miRNA 
profiles correlate strongly
We previously reported that a comparison of Agilent
microarray profiling and SYBR green-based quantitative
RT-PCR (qPCR) of ten miRNAs in seven different human
tissues found the two measurements correlated quite well
[26]. To perform a more extensive comparison, we ana-
lyzed the expression of 61 human miRNAs in nine differ-
ent tissues (brain, breast, heart, liver, placenta, testes,
ovary, skeletal muscle, thymus), using both Agilent
miRNA microarrays and TaqMan stem-loop qRT-PCR
[15]. Aliquots of the same RNA samples were used for
both the microarray and qPCR measurements. We chose
these particular 61 miRNAs for several reasons. First, they
represent a wide range of expression levels, as determined
in an initial array analysis of some of the tissues. Second,
they have wide differences in GC content, ranging from
23% (miR-190) to 68% (miR-328). Third, we chose sev-
eral miRNAs which had potentially problematic
sequences or exhibited atypical behavior during the devel-
opment of the Agilent microarray platform: two of these
did not show as good a linear titration curve as other miR-
NAs tested in a previous study (miR-126*, miR-296) [26],
and two other miRNAs were previously reported not to be
labeled by enzymatic methods similar (but not identical)
to that used with the Agilent microarray assay (miR-208,
miR-219) [33].
Of the 61 miRNAs examined, only miR-637 was not
detected by either method in any of the tissues. The rest of
the miRNAs assayed were detected in most or all of the tis-
sues by both methods, with two exceptions: miR-208,
expressed only in the heart [34] and at very low levels in
skeletal muscle, and miR-138, expressed in the brain, and
at lower levels in placenta and thymus (all data is shown
in Additional File 1).BMC Biotechnology 2008, 8:69 http://www.biomedcentral.com/1472-6750/8/69
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The qPCR and microarray results were compared by plot-
ting the qPCR cycle threshold (Ct) value versus the log2 of
the array signal for each miRNA in all nine tissues (repre-
sentative plots are shown in Figure 1, with the remaining
plots shown in Additional Files 2, 3, 4, 5, 6, 7). These two
values should be directly comparable, since both the
qPCR Ct value and the log2  of the microarray signal
change by a value of 1 for every 2-fold change in miRNA
concentration. If the qPCR and microarray measurements
are equivalent, the plots will show a linear correlation (R
= -1) with a slope of -1. Figure 2 shows the slopes and the
correlation values for each of the 60 miRNAs. 56 of the 60
miRNAs show correlation values (R) between -0.8 and -
1.0, and 50/60 plots have slopes between -1.2 and -0.8. Of
the four miRNAs which were selected as potentially prob-
lematic in the microarray measurements, only miR-296
did not correlate between the microarray and qPCR
assays; miR-208, miR-219, and miR-126* all gave excel-
lent correlations.
To examine the results for all 60 miRNAs on one plot, we
cannot simply plot qPCR Ct values versus microarray sig-
Comparison of qPCR and microarray miRNA profiling for individual miRNAs in nine human tissues Figure 1
Comparison of qPCR and microarray miRNA profiling for individual miRNAs in nine human tissues. Scatter 
plots are shown for 9 of the 61 miRNAs assayed, with qPCR results (cycle threshold (Ct) values) on the x axes and microarray 
results (log2 of the total gene signal) on the y axes. Each data point represents one tissue. All plots are drawn to the same scale. 
The equations and R values on each plot are for the orthogonally-fitted line. Spot colors indicate the tissue: red = breast, pink 
= testes, dark blue = heart, light blue = placenta, dark green = liver, light green = ovary, orange = brain, brown = skeletal mus-
cle, and grey = thymus. Tissues where qPCR results were flagged as "undetermined" by ABI software, or where log2 of the 
total gene signal on arrays was < 1, were not plotted. Error bars indicate standard deviation (SD) of Ct values for qPCR results 
and (SD/Mean)*log2e of the signals for the array results. Scatter plots for the remaining 51 miRNAs (one miRNA gave no sig-
nals with either qPCR or arrays) are in Additional Files 2, 3, 4, 5, 6, 7.
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nals for all miRNAs in all tissues, because both the qPCR
and microarray assays have differential sensitivities to dif-
ferent miRNAs. Thus, instead of looking at absolute
expression levels, we must look at relative ratios of miRNA
expression between two different tissues. To judge the
consistency of fold-changes measured by microarray and
qPCR platforms, we plotted the ratios of miRNA expres-
sion between all 36 possible pairs of tissues as measured
by qPCR (Ct(tissue1)-Ct(tissue2)) and by microarrays
(log2(signal in tissue1)-log2(signal in tissue2)). Four
such plots are shown in Figure 3 (the other 32 plots are
shown in Additional Files 8, 9, 10, 11, 12, 13, 14, 15),
while Figure 4 shows the slopes and R values for each of
the plots for the 36 tissue pairs. The plots all show very
good correlation between the qPCR and array ratios, with
R values between -0.984 and -0.821. The slopes of the 36
plots vary between -1.05 and -0.793. The intercepts of
these fold-change plots (shown in Figures 3 and Addi-
tional Files 8, 9, 10, 11, 12, 13, 14, 15) indicate the con-
sistency between fold-changes measured by the two
methods. The mean of the intercepts of the line fits for the
36 tissue pairs was 0.00 +/- 0.23 (1 SD) (data not shown).
This level of variability (17%) is comparable to that seen
among independent measurements using the same tech-
nique.
Measurements of spike-ins of miRNAs which 
systematically differ between platforms show linear 
sensitivity
miR-494, miR-296, and miR-99a are the three miRNAs
that exhibit the most discrepant correlation values and
slopes between the qPCR and microarray assays (Fig. 2);
however, if the measurement of miR-99a in placenta is
omitted, the slope for this miRNA becomes -0.844 with R
= -0.929 (see plot in Fig. 1). For miR-494 and miR-296, if
one platform were measuring levels of these miRNAs
accurately, while the other platform were not, then we
might expect a significant divergence from linearity to be
observed between the two measurements when adding
increasing amounts of synthetic miR-494 or miR-296
RNA into a total RNA sample. To test this, we added 1
zmol to 10 fmols of synthetic miR-296 and miR-494
RNAs to 100 ng of total RNA from liver or placenta, and
measured the qPCR and microarray responses (Figure 5).
Slope and R values for all 60 miRNA scatter plots Figure 2
Slope and R values for all 60 miRNA scatter plots. The slopes and R values for the orthogonal fit lines for all 60 of the 
miRNAs plotted in Figure 1 and Additional Files 2, 3, 4, 5, 6, 7 are ordered by the slope values. Slopes are shown in blue and R 
values are in red.
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For both miRNAs, in both tissues, the relation between
qPCR measurement and array measurement is linear
above a threshold spike-in concentration. The R values of
the linear regions are very close to -1, with slopes between
-0.842 and -0.935, indicating that both the qPCR and the
microarrays are producing sample-responsive and inter-
nally consistent measurements of miR-296 and miR-494
at these concentration levels. Below the threshold spike-in
levels, the qPCR Ct values and microarray signals are
unchanged for miR-494, while for miR-296 the Ct values
increase slightly, but the array measurements are
unchanged. We conclude that the difference between the
two platforms is not due to different sensitivity, since both
the microarray and qPCR measurements are capable of
measuring miR-296 and miR-494 accurately above a
spike-in concentration threshold. Presumably some type
of interference confounds the measurement of endog-
enous expression levels in the complex sample, on one or
both of the platforms.
Three different total RNA preparation methods show 
similar yields and quality
A question which arises when comparing the miRNA pro-
filing results reported in different studies is whether the
methods used to isolate RNA from tissue or cell line sam-
ples systematically affect the miRNA profiles. To examine
whether the miRNA profile of a sample is affected by the
type of total RNA prep method used, we prepared one
Comparison of qPCR and microarray miRNA measurements for 60 miRNAs in four tissue pairs Figure 3
Comparison of qPCR and microarray miRNA measurements for 60 miRNAs in four tissue pairs. Scatter plots 
are shown for miRNA expression ratios in four different tissue pairs, as determined by qPCR (x axis) and microarrays (y axis), 
where each data point represents one miRNA. The qPCR values are the difference between the Ct values from the two tis-
sues, and the microarray values are the difference between the log2(total gene signals) from the two tissues. The equations and 
R values on each plot are for the orthogonally-fitted line. Scatter plots for the remaining 32 tissue pairs are shown in Additional 
Files 8, 9, 10, 11, 12, 13, 14, 15. SkM = Skeletal Muscle.
Testes/Thymus Brain/Breast
Placenta/SkM Heart/Liver
51 0 1 5 -5 -10 -15 -20 0
-20
-15
-10
-5
0
5
10
15
20
-20
-15
-10
-5
0
5
10
15
20
-20
-15
-10
-5
0
5
10
15
20
-20
-15
-10
-5
0
5
10
15
20
A
r
r
a
y
s
 
(
l
o
g
2
A
-
l
o
g
2
B
)
A
r
r
a
y
s
 
(
l
o
g
2
A
-
l
o
g
2
B
)
A
r
r
a
y
s
 
(
l
o
g
2
A
-
l
o
g
2
B
)
A
r
r
a
y
s
 
(
l
o
g
2
A
-
l
o
g
2
B
)
y = -0.175 – 0.822x, R = -0.968 y = -0.038 – 0.982x, R = -0.984
y = -0.276 – 0.972x, R = -0.951 y = -0.073 – 0.926x, R = -0.972
5 1 01 52 0 -5 -10 -15 -20 0 20
5 1 01 52 0 -5 -10 -15 -20 0 5 1 01 52 0 -5 -10 -15 -20 0
qPCR (CtA-CtB)
qPCR (CtA-CtB)
qPCR (CtA-CtB)
qPCR (CtA-CtB)BMC Biotechnology 2008, 8:69 http://www.biomedcentral.com/1472-6750/8/69
Page 6 of 16
(page number not for citation purposes)
large frozen cell pellet from each of two different human
cell lines, HeLa (a cervical carcinoma line) and ZR-75-1 (a
breast carcinoma line). We then subdivided these pellets
into equal aliquots, and performed total RNA isolation on
the aliquots using three different techniques: phenol/gua-
nidinium (TRIzol, Invitrogen) followed by isopropanol
precipitation, and two column-based techniques, miRNe-
asy (QIAGEN) and mirVana (ABI). Four to eleven replicate
preps were performed on each cell type with each method.
Mean RNA yields, as measured by absorbance at 260 nm,
and quality metrics for each prep type are shown in Table
1. The RNA integrities of the preps were analyzed on the
Agilent 2100 Bioanalyzer, and all the preps had high qual-
ity RNA according to the RIN number [35,36]. This indi-
cates that most of the RNAs in the various preps were
intact, with minimal breakdown. However, RIN values do
not provide information about non-RNA contaminants,
such as organic reagents and DNA. The TRIzol preps
showed the lowest mean 260/230 ratios, possibly indicat-
ing the presence of some remaining TRIzol reagent in the
final product.
Since the absorbance at 260 nm is used to quantitate the
amount of RNA for use in the measurement assays, and
since the 260:230 ratios can only serve as a crude guide-
line to possible contaminants, it is important to examine
the absorption spectra in more detail (Figure 6). Some of
the spectra clearly show the presence of additional peaks
between 220–230 nm, indicating the presence of contam-
Slope and R values for all 36 tissue pair plots Figure 4
Slope and R values for all 36 tissue pair plots. The slopes and R values for the orthogonal fit lines for all 36 possible tissue 
pairs plotted in Figure 3 and Additional Files 8, 9, 10, 11, 12, 13, 14, 15 are ordered by the slope values. Slopes are shown in 
blue and R values are in red.
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Comparison of qPCR and microarray measurements for miR-296 and miR-494 titrations Figure 5
Comparison of qPCR and microarray measurements for miR-296 and miR-494 titrations. Scatter plots are shown 
for titration of synthetic miR-296 into liver (top left panel) and placenta (top right panel) total RNAs, and miR-494 into liver 
(lower left) and placenta (lower right) total RNAs. Ct values from qPCR are plotted on the x-axis, while log2 of the total gene 
signal from microarray measurements are plotted on the y-axis. Numbers in red show the number of attomoles of spike-in 
miRNA per 100 ng total RNA. Equations and R values are for the orthogonal line fit of the linear regions of each titration. 
Error bars indicate standard deviation (SD) of Ct values for qPCR results and (SD/Mean)*log2e for the array results.
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Table 1: List and characteristics of sample preps from HeLa and ZR-75-1 cell pellets. 
Cell Line Prep Type No. of Preps RNA Yield Mean (SD) 260:280 Mean (SD) 260:230 Mean (SD) RIN Mean (SD)
HeLa TRIzol 10 45.59 (7.17) 1.89 (0.0406) 1.28 (0.208) 9.9 (0.14)
HeLa mirVana 8 43.16 (12.01) 1.96 (0.0364) 1.36 (0.323) 9.9 (0.11)
HeLa miRNeasy 11 34.07 (5.40) 2.08 (0.00874) 1.97 (0.389) 9.9 (0.11)
ZR-75-1 TRIzol 4 23.52 (1.39) 1.84 (0.0432) 0.815 (0.0759) 9.8 (0.075)
ZR-75-1 mirVana 4 16.92 (5.84) 2.01 (0.0356) 1.28 (0.361) 9.1 (0.17)
ZR-75-1 miRNeasy 4 18.37 (1.93) 2.05 (0.0311) 1.87 (0.337) 9.8 (0.050)
The number of individual preps performed using the indicated total RNA prep method and cell lines are shown, as are the mean and standard 
deviations (in parentheses) of the total RNA yields (in micrograms), 260:280 ratios, 260:230 ratios, and RIN numbers for all the preps done with the 
same method in each cell type. Preps started with either 5 × 106 cells (HeLa) or 1 × 107 cells (ZR-75-1).BMC Biotechnology 2008, 8:69 http://www.biomedcentral.com/1472-6750/8/69
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inant(s). While this is most consistently seen in the TRIzol
preps, it is also sometimes seen in the mirVana preps and
in one of the miRNeasy preps. In some of the samples
where no distinct peak is observed between 220–230 nm,
the spectra show significant absorbance in the wave-
lengths immediately below 220 nm, with a shoulder tail-
ing from 220 nm to 240 nm. At 240 nm the absorption
increases again to peak at around 260 nm, which is the
wavelength of maximum absorption for nucleic acids of
mixed oligonucleotide composition. For many of these
spectra, this absorption pattern suggests that the absorb-
ance of the contaminant(s) whose peak is below 240 nm
may overlap with the nucleic acid absorbance peak at 260
nm, which would result in the overestimation of nucleic
acid quantity as determined by the absorption at 260 nm.
Also, a couple of the absorbance spectra show a slight
shoulder in the 260–270 nm range, indicating a contami-
nant which could also affect RNA quantitation. Thus,
careful examination of sample spectra can be important
for identifying samples where measured miRNA levels
might be compromised by absorbance-based RNA quan-
titation artifacts.
Variability of hybridization results is highest between 
different prep methods
For miRNA microarray profiling analysis we took three of
the replicate total RNA preps of each different prep
method in each cell type and hybridized them to Agilent
miRNA microarrays. A total of 42 hybridizations were
done, with all but two samples hybridized at least twice
(Additional File 16).
A good measure of the reproducibility of replicate meas-
urements is the Root Mean Square (RMS) deviation of the
Absorption Spectra of HeLa and ZR-75-1 Sample Preps Figure 6
Absorption Spectra of HeLa and ZR-75-1 Sample Preps. The absorption spectra for the total RNA sample preps (listed 
in Table 1) are shown. Blue traces are HeLa cell preps and red traces are ZR-75-1 cell preps. Spectra are from 220 to 350 nm.
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natural logs of all signals that are well above background
levels. The RMS deviation is approximately equal to the
coefficient of variation of signals, and is an estimate of the
proportional error of the measurement. For example, if
the RMS deviation is 0.15 (15%), then a measured fold
change between samples of 1.15 is a difference of one
standard deviation.
We compared the RMS deviations between pairs of
hybridizations performed using the same total RNA prep
(hybridization replicates) with those performed using dif-
ferent total RNA preps done with the same method (prep
replicates), and also with those using different total RNA
prep methods. We also compared hybridizations per-
formed on the same or different days, in order to take into
account any day-to-day variability in the results. Figure 7a
shows box plots of the RMS deviations between all possi-
ble replicate hybridization pairs, categorized by same or
different prep method, same or different prep replicate,
same or different hybridization replicate, and same or dif-
ferent hybridization day. The box plots for the six different
categories are shown in decreasing order of variability.
Hybridizations using preps from different methods show
the most variability, with same day hybs of the different
prep methods showing slightly less variability than differ-
ent day hybs. Replicate preparations using the same
method are the next lowest in variability, again with same
day hybs being less variable than different day hybs.
Finally, hybs done with aliquots of the same preparation
have the lowest variability, again with same day hybs
being less variable than different day hybs. The three
sources of variability can thus be put in order of their mag-
nitude: different prep methods > different preps using the
same method > different hybridization day.
We also plotted the RMS deviations for hybridizations
involving prep replicate pairs from each of the three differ-
ent prep methods (regardless of the hybridization day), in
order to examine whether the different prep methods
showed different amounts of variation between prep rep-
licates (Figure 7b). The TRIzol prep replicates showed less
variability than the other two prep methods. A Student's t-
test between pair-wise comparisons of the three prep
methods confirmed that this difference is statistically sig-
nificant (data not shown). There was no significant differ-
ence in variability between the mirVana and miRNeasy
prep replicates.
A small subset of miRNAs differ between prep methods
To examine whether there are systematic differences
among the miRNA profiles observed for RNA isolated by
different methods, we first looked at the overall signal lev-
els of the hybridizations. The grand means of the mean
total gene signal for all hybridizations of the same prep
type for each cell line are shown in Table 2. For both cell
types, the miRNeasy preps gave about 25% higher overall
signals than the other two prep methods. The overall sig-
nal differences between the TRIzol and mirVana preps of
the same cell type were minimal. It should be noted that
the miRNeasy preps had the highest 260:230 ratios (Table
1), and their spectra generally showed lower absorbance
in the 220–230 nm range compared to the other two prep
types. It is possible that some of the material which is
absorbing at 220–230 nm in RNA extracted using the
other two methods is contributing to the 260 nm peak,
and it is also possible that DNA contaminants are present.
The presence of either or both types of contaminant can
lead to an overestimation of the amount of RNA present
in these preps.
We next examined whether specific miRNAs systemati-
cally differ among the different prep methods (Figures 8
and 9). We calculated an average expression profile for
each prep method for the two cell lines, by first averaging
the total gene signals for each miRNA from all hybridiza-
tions of the same RNA prep, and then averaging together
these individual prep averages for all preps of the same
prep and cell type. Since there were differences seen in the
overall signal levels between the different preps (Table 2),
we normalized each pair-wise comparison to the 75th per-
centile of one of the pairs. The expression profile of most
miRNAs in HeLa cells does not depend on the RNA prep
method (Figure 8). However, there is a small subset of
miRNAs that consistently report different relative expres-
sion levels depending on the prep method. The miRNAs
that are labeled in the figure show expression levels that
differ by at least 2-fold in different prep methods. Addi-
tional File 17 lists the miRNAs which are 1.5x and 2x
higher in one prep type compared to another. Three miR-
NAs are found at consistently lower levels in TRIzol preps
than in the other two preps: miR-29b, miR-33, and miR-
219. mirVana preps show consistently higher levels of four
miRNAs when compared to the other two HeLa preps:
miR-149, miR-328, miR-574, and miR-766. Figure 9 (and
Additional File 17) shows the results from the ZR-75-1
breast cell line. While fewer miRNAs show different pro-
files among the three different prep methods in this cell
line compared to HeLa, four out of the five that are
observed to be discrepant in ZR-75-1 cells are the same as
those seen in HeLa cells (miR-29b, miR-33, miR-219, and
miR-328).
The finding that a small number of miRNAs report differ-
ent microarray signals when prepared by different meth-
ods raises the question of whether these differences reflect
real differences in the concentrations of these miRNAs in
the different sample preps. To examine this, we assayed
individual samples prepared with the three methods by
qPCR, using primers for three of the miRNAs showing dif-
ferences between the prep methods. We then comparedBMC Biotechnology 2008, 8:69 http://www.biomedcentral.com/1472-6750/8/69
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these results to those obtained from microarray analysis
of the same preps (Figure 10). The good agreement of the
qPCR results with the array results for these miRNAs
strongly suggests that the differences in the miRNA levels
observed between the sample prep methods reflect true
differences in the miRNA content of the extracted RNA,
and are not artifacts of the measurement assay. At present,
we have no explanation for why these particular miRNAs
are found at different levels when using different extrac-
tion techniques.
Conclusion
In this study we compared the expression levels of 61
miRNAs in nine human tissues as measured by both Agi-
lent microarrays and TaqMan qRT-PCR. We found that
53/60 expressed miRNAs had correlations (R) > 0.9
between the two methods. For the two miRNAs that dif-
fered most between the two methods, spike-in studies
found the differences are not due to differential sensitivity
of the two methods, but are more likely due to interfer-
ence from other RNAs in the complex mixture.
We also examined microarray-based miRNA profiles
using three different total RNA sample prep methods. We
found that while almost all miRNA levels correspond
between the three different prep methods, a small subset
of 2–10 miRNAs consistently differ by greater than 2-fold
between different techniques. These differences were cor-
roborated using qPCR, and are most likely due to true dif-
ferences in the miRNA content of the extracted RNA. Thus,
while all three methods are suitable for use in profiling
miRNAs from total RNA, it may be prudent to pick one
method and use it for the entire course of any particular
study, in order to avoid these small profile differences due
to the RNA preparation method.
Methods
Total RNA and cell samples
Total RNA samples from normal human tissues were from
Ambion (Austin, TX). Frozen HeLa cell pellets were from
Cell Trends (Middletown, MD), and frozen ZR-75-1 cell
pellets were from BioProcessing Inc. (Portland, ME).
miRNA microarray analysis
miRNA microarrays were manufactured by Agilent Tech-
nologies (Santa Clara, CA)., and contain 20–40 features
targeting each of 470 human miRNAs (Agilent design IDs
015508 (sample prep studies) and 016436 (nine tissue
comparison studies)) [37]. Sequences of the 470 miRNAs
were obtained from the Sanger miRBase, release 9.1 [10-
12]. Labeling and hybridization of total RNA samples
were performed according to the manufacturer's protocol.
100 ng total RNA was used as input into the labeling reac-
tion, and the entire reaction was hybridized to the array
for 20 hours at 55°C. For the microarray versus qRT-PCR
comparisons, the labeling and hybridizations of the nine
human tissues were done 4–5 times, and the mean and
standard deviation for each miRNA were calculated.
Microarray results were extracted using Agilent Feature
Extraction software (v9.5.3.1) and analyzed using Gene-
Spring GX 7.3.1 software (Agilent Technologies) and
Spotfire DecisionSite 8.1 software (TIBCO Software, Palo
Alto, CA). Box plots were calculated using JMP 5.1 soft-
ware (SAS, Cary, NC). Original microarray data is depos-
ited in the Gene Expression Omnibus [38] (Series
GSE11879).
Box plots of RMS deviations for microarray hybridization pairs Figure 7
Box plots of RMS deviations for microarray hybridization pairs. (a) RMS deviations of all possible hybridization 
pairs of the same cell type. Box plots show the distribution of RMS deviations calculated from all possible pairs of hybridi-
zations done with the same cell type, and sorted by prep type, prep replicate, and hybridization day. Plots show the combined 
results from HeLa and ZR-75-1 cells. Each replicate pair RMS deviation is indicated by a black dot. The ends of the box repre-
sent the 25th and 75th quartiles, while the line through the center of the box represents the median. The whiskers from each 
box extend to the outermost data point included in the range from the upper quartile plus 1.5*(interquartile range) to the 
lower quartile minus 1.5*(interquartile range). The line across the entire plot indicates the mean of all the values. Values of the 
mean and standard deviations for each set of values are shown at the bottom of the plot. (b) RMS deviations of all prep 
replicate hybridization pairs, sorted by prep type. Box plots of the RMS deviations for all the pair-wise comparisons of 
hybridizations using replicates of the same prep type, and sorted by prep type. Plots show the combined results from HeLa and 
ZR-75-1 cells. Box plot details are as in Figure 7a.
Table 2: Grand means of the mean total gene signal for all 
hybridizations of each prep type. 
Cell Line Prep Type Mean TGS (SD)
HeLa TRIzol 235.0 (19.1)
HeLa mirVana 211.2 (25.8)
HeLa miRNeasy 290.3 (19.2)
ZR-75-1 TRIzol 407.9 (33.0)
ZR-75-1 mirVana 437.1 (84.5)
ZR-75-1 miRNeasy 546.7 (41.9)
The mean of the total gene signal for all the miRNAs on the 
microarray were calculated for each individual hybridization, and the 
mean and standard deviation of these for each prep type in each cell 
line are shown.BMC Biotechnology 2008, 8:69 http://www.biomedcentral.com/1472-6750/8/69
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All scatter plots of miRNA microarray data use the total
gene signal, which is proportional to the total number of
targets bound by the probes targeting each miRNA
[31,32]. For comparison of two hybridizations, the natu-
ral logs of the total gene signals for all genes expressing
above 10x the background noise in both samples were
regressed against each other, and the standard deviation
of the residuals from the regression line were reported as
the RMS deviation. For most pairs of samples prepared by
the same method, residuals were normally distributed, so
that the RMS deviation describes true random variation in
the assay. In pairs of samples prepared by different meth-
ods, residuals of most of the miRNAs were also normally
distributed, with systematic exceptions of some miRNAs
as discussed in the text. No normalization was performed
for either microarray or qPCR data, except for an overall
intensity normalization applied to the average signals
from different prep methods, as described in the text (Fig-
ures 8 and 9). For this comparison, the 75th percentile of
the total gene signal for all the miRNAs on the array was
calculated by sorting the total gene signals for 470 miR-
NAs on the array in ascending order, and the signals from
the three methods were normalized to the signal from the
353rd miRNA.
miRNA qRT-PCR analysis
miRNA qRT-PCR analysis was performed using Taqman
miRNA assays (Applied Biosystems, Foster City, CA),
Pair-wise comparisons of averaged profiles of the three different prep types: HeLa cells Figure 8
Pair-wise comparisons of averaged profiles of the three different prep types: HeLa cells. Total gene signals for 
each miRNA for all hybridizations of the same RNA prep (hybridization replicates) were averaged, and then these averaged 
individual prep profiles for all the preps of the same prep type were averaged together to get a mean profile for each of the 
three prep types. Scatter plots show these averaged profiles from one prep type plotted against another for HeLa cells. Error 
bars indicate one standard deviation. Numbers indicate the identity of all miRNAs whose signal strengths are at least two-fold 
higher in one prep type than another, after normalization.
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according to the manufacturer's protocol. 5 ng total RNA
was input into each reverse transcription reaction (RT) for
each miRNA. Four replicates were done for each miRNA,
consisting of two replicate PCR reactions from each of the
two replicate RT reactions, and the results were averaged.
PCR reactions were run on a 7500 Real Time PCR
machine (Applied Biosystems) and analyzed using 7500
System SDS software (v1.4).
miRNA spike-ins
Synthetic miRNAs were manufactured by TriLink Bio-
Technologies (San Diego, CA) and spiked into human
liver and placenta total RNA (Ambion). 100 ng of these
RNA mixes were then used for labeling and hybridization
onto the microarrays, while 5 ng were used as input into
the reverse transcriptase reaction for qPCR. Two replicate
microarray hybridizations and four replicate qPCR reac-
tions were done for each dilution in each tissue.
Total RNA sample preps
Frozen cell pellets were resuspended in phosphate buff-
ered saline and divided into equal aliquots of 5 × 106
(HeLa) or 1 × 107 (breast) cells and refrozen. Individual
aliquots were subsequently thawed just before use.
TRIzol preps were performed according to the manufac-
turer's protocol (Invitrogen, Carlsbad, CA) using an iso-
propanol precipitation. Briefly, 1 ml of TRIzol reagent was
added to the cell pellet and cells were lysed by repetitive
pipetting, and then incubated at room temperature for 5
minutes. 200 μl of chloroform were added, followed by
vigorous shaking and incubation for 2–3 minutes at room
temperature. Samples were centrifuged 15 minutes at
Pair-wise comparisons of averaged profiles of the three different prep types: ZR-75-1 preps Figure 9
Pair-wise comparisons of averaged profiles of the three different prep types: ZR-75-1 preps. Scatter plots as in 
Figure 8, but for ZR-75-1 cell preps.
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12000 × g at 4°C. The aqueous layer was transferred to a
new tube, and the RNA was precipitated by adding 0.5 ml
isopropanol, incubating 10 minutes at room temperature,
and spinning for 10 minutes (12000 × g at 4°C). Pellets
were washed with 80% ethanol and resuspended in nucle-
ase-free dH2O (Ambion).
miRNeasy total RNA preps (QIAGEN, Valencia, CA) were
performed according to the manufacturer's protocol. The
mirVana miRNA Isolation kit (Applied Biosystems) was
used according to the manufacturer's protocol for total
RNA isolation.
All total RNA preps were analyzed using the 2100 Bioan-
alyzer (Agilent Technologies), RNA 6000 Nano LabChip
kits, and 2100 expert software (version B.02.05.SI360).
Absorption spectra were measured on an ND-1000 spec-
trophotometer (NanoDrop Technologies, Wilmington,
DE).
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Comparison of qPCR and microarray miRNA results for three miRNAs differentially measured between different prep types Figure 10
Comparison of qPCR and microarray miRNA results for three miRNAs differentially measured between dif-
ferent prep types. Individual TRIzol, miRNeasy, and mirVana preps were assayed with qPCR for three miRNAs found in 
microarray studies to be at higher levels in one prep type than another. Scatter plots show qPCR results (cycle threshold (Ct) 
values) on the x axes and microarray results (log2 of the total gene signal) on the y axes. Each data point represents one indi-
vidual prep from one cell type. Circles indicate HeLa preps and triangles represent ZR-75-1 preps. TRIzol preps are in red, 
miRNeasy preps are in green, and mirVana preps are in blue. The equations and R values on each plot are for the line of best fit. 
Error bars indicate standard deviation (SD) of Ct values for qPCR results and (SD/Mean)*log2e for the array results. Note that 
the axes are not on the same scale in the three different plots.
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Comparison of qPCR and microarray miRNA profiling for individual 
miRNAs. Scatter plots for 51 miRNAs not shown in Figure 1.
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Comparison of qPCR and microarray miRNA profiling for individual 
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